Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study.
Potena
Luciano
L
Bianchi
Isidoro G
IG
Magnani
Gaia
G
Masetti
Marco
M
Coccolo
Fabio
F
Fallani
Francesco
F
Russo
Antonio
A
Grigioni
Francesco
F
Branzi
Angelo
A
Ponticelli
Claudio
C
D003404:Creatinine / Q000378:metabolism; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D000068338:Everolimus; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology*; D007677:Kidney Function Tests; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012449:Safety; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000068338:Everolimus; D003404:Creatinine; D009173:Mycophenolic Acid; D020123:Sirolimus